LianBio
LIANY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831283
No open-market purchases or sales by LianBio insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.00K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in LianBio as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −4 vs. Q3 2022
- Shares held
- 81.3M
- −2.76M (−3.3%) vs. Q3 2022
- Total value
- $133.3M
- −$34.7M (−20.7%) vs. Q3 2022
- New holders
- 7
- 8 more added
- Sold out
- 11
- 10 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LIANY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $1.00K |
| Q1 2026 | 1 | $1.00K |
| Q4 2025 | 1 | $1.00K |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $5.00K |
| Q1 2025 | 1 | $2.00K |
| Q4 2024 | 2 | $42.1K |
| Q3 2024 | 2 | $47.3K |
| Q2 2024 | 2 | $50.5K |
| Q1 2024 | 3 | $49.2K |
| Q4 2023 | 29 | $377.3M |
| Q3 2023 | 38 | $117.7M |
| Q2 2023 | 39 | $182.9M |
| Q1 2023 | 36 | $157.1M |
| Q4 2022 | 40 | $133.3M |
| Q3 2022 | 44 | $168.0M |
| Q2 2022 | 44 | $187.1M |
| Q1 2022 | 37 | $318.6M |
| Q4 2021 | 36 | $550.5M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding LianBio; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 57,558,451 | $94.4M | 2.72% | 00.0% | Unchanged |
| VR Adviser, LLC | 4,793,047 | $7.86M | 1.32% | −585,294−10.9% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,564,173 | $5.85M | 0.03% | 00.0% | Unchanged |
| Tybourne Capital Management (HK) Ltd | 3,303,573 | $5.42M | 0.54% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,681,497 | $4.40M | 0.00% | −141,360−5.0% | Reduced |
| Vida Ventures Advisors, LLC | 2,282,084 | $3.74M | 5.03% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,032,084 | $1.69M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 1,023,107 | $1.68M | 0.00% | 00.0% | Unchanged |
| SCHF (Gpe), LLC | 937,500 | $1.54M | 2.99% | 00.0% | Unchanged |
| Citigroup Inc | 707,336 | $1.16M | 0.00% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 650,000 | $1.07M | 0.49% | +100,000+18.2% | Added |
| Millennium Management LLC | 320,518 | $526.0K | 0.00% | +110,128+52.3% | Added |
| Renaissance Technologies LLC | 290,622 | $477.0K | 0.00% | −24,378−7.7% | Reduced |
| Logos Global Management LP | 280,000 | $459.2K | 0.05% | −27,908−9.1% | Reduced |
| Casdin Capital, LLC | 206,415 | $338.5K | 0.03% | 00.0% | Unchanged |
| TD Asset Management Inc | 178,519 | $292.8K | 0.00% | 00.0% | Unchanged |
| Innovis Asset Management LLC | 176,192 | $289.0K | 0.13% | +176,192 | New |
| Cornercap Investment Counsel Inc | 165,718 | $271.8K | 0.05% | +83,888+102.5% | Added |
| Citadel Advisors LLC | 142,193 | $233.2K | 0.00% | −697,976−83.1% | Reduced |
| 22NW, LP | 141,223 | $231.6K | 0.13% | 00.0% | Unchanged |
| MYDA Advisors LLC | 135,000 | $221.4K | 0.16% | +15,000+12.5% | Added |
| Barclays PLC | 128,728 | $211.1K | 0.00% | −139,672−52.0% | Reduced |
| Manufacturers Life Insurance Company, The | 117,484 | $182.1K | 0.00% | 00.0% | Unchanged |
| Thrivent Financial for Lutherans | 81,168 | $133.0K | 0.00% | +209+0.3% | Added |
| Victory Capital Management Inc | 64,506 | $105.8K | 0.00% | −108,954−62.8% | Reduced |
| Tang Capital Management LLC | 59,600 | $97.7K | 0.01% | +59,600 | New |
| HighTower Advisors, LLC | 48,500 | $80.0K | 0.00% | +9,500+24.4% | Added |
| Jane Street Group, LLC | 47,583 | $78.0K | 0.00% | +47,583 | New |
| Old Well Partners, LLC | 32,200 | $52.8K | 0.05% | 00.0% | Unchanged |
| Vident Investment Advisory, LLC | 28,616 | $46.9K | 0.00% | 00.0% | Unchanged |
| Stifel Financial Corp | 21,250 | $34.9K | 0.00% | +21,250 | New |
| Gsa Capital Partners LLP | 19,482 | $32.0K | 0.00% | −106,490−84.5% | Reduced |
| Virtu Financial LLC | 17,456 | $29.0K | 0.00% | +17,456 | New |
| Bank of America Corp | 12,532 | $20.6K | 0.00% | +4,355+53.3% | Added |
| Commonwealth Equity Services, LLC | 10,830 | $17.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,519 | $14.0K | 0.00% | −12,254−59.0% | Reduced |
| UBS Group AG | 4,024 | $6.60K | 0.00% | +2,777+222.7% | Added |
| Morgan Stanley | 1,001 | $1.64K | 0.00% | −54,145−98.2% | Reduced |
| Cary Street Partner Investment Advisory LLC | 1,000 | $1.64K | 0.00% | +1,000 | New |
| Royal Bank of Canada | 10 | $0 | 0.00% | +10 | New |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −713,743−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −429,186−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −206,497−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −58,490−100.0% | Sold out |
| Powell Investment Advisors, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −23,245−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −19,606−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,157−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −11,500−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −10,650−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −178−100.0% | Sold out |